Ethic Inc’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.16M | Buy |
159,588
+18,499
| +13% | +$714K | 0.11% | 193 |
|
|
2025
Q1 | $5.34M | Buy |
141,089
+34,185
| +32% | +$1.29M | 0.11% | 204 |
|
|
2024
Q4 | $3.62M | Buy |
106,904
+8,586
| +9% | +$290K | 0.07% | 279 |
|
|
2024
Q3 | $4.21M | Sell |
98,318
-26,213
| -21% | -$1.12M | 0.11% | 222 |
|
|
2024
Q2 | $4.79M | Buy |
124,531
+26,213
| +27% | +$1.01M | 0.11% | 196 |
|
|
2024
Q1 | $4.21M | Buy |
98,318
+1,074
| +1% | +$46K | 0.11% | 222 |
|
|
2023
Q4 | $3.6M | Buy |
97,244
+18,100
| +23% | +$671K | 0.11% | 223 |
|
|
2023
Q3 | $2.87M | Sell |
79,144
-19,914
| -20% | -$722K | 0.1% | 246 |
|
|
2023
Q2 | $3.53M | Sell |
99,058
-328
| -0.3% | -$11.7K | 0.13% | 190 |
|
|
2023
Q1 | $3.54M | Buy |
99,386
+6,146
| +7% | +$219K | 0.14% | 185 |
|
|
2022
Q4 | $3.28M | Buy |
93,240
+9,327
| +11% | +$328K | 0.18% | 149 |
|
|
2022
Q3 | $2.47M | Sell |
83,913
-5,610
| -6% | -$165K | 0.17% | 152 |
|
|
2022
Q2 | $4.87M | Buy |
89,523
+9,403
| +12% | +$512K | 0.34% | 64 |
|
|
2022
Q1 | $4.36M | Buy |
80,120
+26,784
| +50% | +$1.46M | 0.3% | 78 |
|
|
2021
Q4 | $2.94M | Buy |
53,336
+15,802
| +42% | +$871K | 0.23% | 108 |
|
|
2021
Q3 | $1.79M | Buy |
37,534
+22,258
| +146% | +$1.06M | 0.18% | 141 |
|
|
2021
Q2 | $760K | Buy |
15,276
+9,249
| +153% | +$460K | 0.09% | 262 |
|
|
2021
Q1 | $269K | Sell |
6,027
-10,367
| -63% | -$463K | 0.05% | 408 |
|
|
2020
Q4 | $754K | Buy |
16,394
+2,800
| +21% | +$129K | 0.2% | 126 |
|
|
2020
Q3 | $640K | Buy |
13,594
+2,716
| +25% | +$128K | 0.24% | 105 |
|
|
2020
Q2 | $555K | Buy |
10,878
+3,146
| +41% | +$161K | 0.32% | 83 |
|
|
2020
Q1 | $366K | Buy |
7,732
+2,343
| +43% | +$111K | 0.31% | 111 |
|
|
2019
Q4 | $317K | Buy |
+5,389
| New | +$317K | 0.23% | 145 |
|